Waterhouse, D. M., Rothschild, S., Dooms, C., Mennecier, B., Bozorgmehr, F., Majem, M., . . . Novello, S. (2024). Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation. Lung cancer, 196, . https://doi.org/10.1016/j.lungcan.2024.107921
Chicago-Zitierstil (17. Ausg.)Waterhouse, David M., et al. "Patient-reported Outcomes in CodeBreaK 200: Sotorasib Versus Docetaxel for Previously Treated Advanced NSCLC with KRAS G12C Mutation." Lung Cancer 196 (2024). https://doi.org/10.1016/j.lungcan.2024.107921.
MLA-Zitierstil (9. Ausg.)Waterhouse, David M., et al. "Patient-reported Outcomes in CodeBreaK 200: Sotorasib Versus Docetaxel for Previously Treated Advanced NSCLC with KRAS G12C Mutation." Lung Cancer, vol. 196, 2024, https://doi.org/10.1016/j.lungcan.2024.107921.